Compumedics Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Compumedics şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Geri Alım Getirisi

Toplam Hissedar Getirisi	n/a
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Oct 24

Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce

Jun 17

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Oct 19

Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Oct 14

Is Compumedics (ASX:CMP) Using Debt Sensibly?

May 02

Compumedics (ASX:CMP) May Have Issues Allocating Its Capital

Dec 08

Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends

Aug 09

Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden

Jun 10

Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)

May 06

These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively

Feb 25

How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?

Dec 01

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: CMP şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: CMP şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Compumedics Piyasaya Karşı Temettü Getirisi

CMP temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (CMP)	n/a
Pazarın Alt %25'i (AU)	2.6%
Pazarın En İyi %25'i (AU)	6.1%
Sektör Ortalaması (Medical Equipment)	1.6%
Analist tahmini (CMP) (3 yıla kadar)	n/a

Önemli Temettü: CMP şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, CMP şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: CMP şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: CMP herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Compumedics Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate

Full year 2024 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in FY 2023)

Compumedics Limited, Annual General Meeting, Oct 31, 2024

Full year 2024 earnings released: AU$0.001 loss per share (vs AU$0.035 loss in FY 2023)

New minor risk - Shareholder dilution

Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce

New minor risk - Share price stability

Returns On Capital Signal Difficult Times Ahead For Compumedics (ASX:CMP)

New major risk - Share price stability

We Think Compumedics (ASX:CMP) Has A Fair Chunk Of Debt

Full year 2023 earnings released: AU$0.035 loss per share (vs AU$0.008 profit in FY 2022)

Compumedics Limited, Annual General Meeting, Oct 31, 2023

Full year 2023 earnings released: AU$0.004 loss per share (vs AU$0.008 profit in FY 2022)

Compumedics Limited Provides Revenue Guidance for the Year 2023

Is Compumedics (ASX:CMP) A Risky Investment?

Compumedics Limited Re-Affirms Earnings Guidance for the Fiscal Year 2023

First half 2023 earnings released: AU$0.041 loss per share (vs AU$0.002 profit in 1H 2022)

Compumedics (ASX:CMP) Could Be At Risk Of Shrinking As A Company

Compumedics Limited Provides Revenue Guidance for the First Half of Fiscal Year 2023

No independent directors

Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year

Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly

Full year 2022 earnings released: EPS: AU$0.008 (vs AU$0.006 in FY 2021)

Compumedics Limited, Annual General Meeting, Oct 27, 2022

Full year 2022 earnings released: EPS: AU$0.008 (vs AU$0.006 in FY 2021)

Compumedics Limited Provides Revenue Guidance for the Fiscal Year 2023

Is Compumedics (ASX:CMP) Using Debt Sensibly?

No independent directors

Tucson Dunn Retires as Director of Compumedics Limited, Effective 31 March, 2022

First half 2022 earnings: EPS and revenues miss analyst expectations

Compumedics (ASX:CMP) May Have Issues Allocating Its Capital

Full year 2021 earnings released: EPS AU$0.006 (vs AU$0.033 loss in FY 2020)

Full year 2021 earnings released: EPS AU$0.006 (vs AU$0.033 loss in FY 2020)

Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends

Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden

Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)

New 90-day low: AU$0.41

These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively

First half 2021 earnings released: EPS AU$0.007 (vs AU$0.001 in 1H 2020)

How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?

Price target lowered to AU$1.00

Compumedics Limited Announces Not to Provide Guidance for the Fiscal Year 2021

Compumedics Limited Announces That Sales Forecasts Will Remain Problematic Due to COVID-19 Pandemic

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin